Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000420601 | SCV000517920 | benign | not specified | 2015-12-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000676494 | SCV001728803 | benign | not provided | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002244879 | SCV002514434 | benign | Combined oxidative phosphorylation defect type 20 | 2021-12-05 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000420601 | SCV005091853 | benign | not specified | 2024-07-31 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 90% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 84. Only high quality variants are reported. |
Mayo Clinic Laboratories, |
RCV000676494 | SCV000802277 | benign | not provided | 2016-03-02 | no assertion criteria provided | clinical testing |